Study Finds ‘Master Switch’ in Fatal Glioblastoma

A study conducted at the University of Virginia School of Medicine has found a means for treating glioblastoma that avoids many of the obstacles that hinder effective treatment of the fatal brain tumor. Researchers have located what they call a “master switch”, an important enzyme that they believe is responsible for cancer cell survival, proliferation and the formation of tumors. Finding this target is exciting, researchers believe, because of the implications it has for brain tumors and other aggressive forms of cancer. For the full story, click here.